{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:02:26Z","timestamp":1770998546684,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1016\/0002-9343(90)90419-e","type":"journal-article","created":{"date-parts":[[2004,6,8]],"date-time":"2004-06-08T12:40:17Z","timestamp":1086698417000},"page":"S27-S30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S2","title":["AIDS clinical trials group: Phase I\/II study of combination 2\u2032,3\u2032-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex"],"prefix":"10.1016","volume":"88","author":[{"given":"Tze-Chiang","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Fischl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas D.","family":"Richman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9343(90)90419-E_BIB1","first-page":"7096","article-title":"3\u2032-Azido-3\u2032-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virus in vitro","volume":"82","author":"Mitsuya","year":"1985"},{"key":"10.1016\/0002-9343(90)90419-E_BIB2","first-page":"1911","article-title":"Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy associated virus (HTLV-III\/LAV) by 2\u2032,3\u2032-dideoxynucleosides","volume":"83","author":"Mitsuya","year":"1986"},{"key":"10.1016\/0002-9343(90)90419-E_BIB3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(86)92808-4","article-title":"Administration of 3\u2032-azido-3\u2032-deoxythymidine, an inhibitor of HTLV-III-\/LAV replication, to patients with AIDS or AIDS-related complex","volume":"I","author":"Yarchoan","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/0002-9343(90)90419-E_BIB4","series-title":"AIDS: modern concepts and therapeutic challenges","first-page":"335","article-title":"Strategies for the pharmacological intervention against HTLV-II\/LAV","author":"Yarchoan","year":"1987"},{"key":"10.1016\/0002-9343(90)90419-E_BIB5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/clpt.1987.49","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of 3\u2032-azido-3\u2032-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases","volume":"41","author":"Klecker","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 2A","key":"10.1016\/0002-9343(90)90419-E_BIB6","first-page":"189","article-title":"Pharmacokinetics and bioavailability of zidovudine in humans","volume":"85","author":"Blum","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/0002-9343(90)90419-E_BIB7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","article-title":"The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial","volume":"317","author":"Fischl","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-9343(90)90419-E_BIB8","unstructured":"Retrovir\u00ae capsules (zidovudine): Burroughs-Wellcome (package insert). Research Triangle Park, North Carolina."},{"key":"10.1016\/0002-9343(90)90419-E_BIB9","series-title":"A double-blind, placebo-controlled trial","first-page":"192","article-title":"The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex","volume":"317","author":"Richman","year":"1987"},{"key":"10.1016\/0002-9343(90)90419-E_BIB10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(88)92903-0","article-title":"Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex","volume":"II","author":"Dournon","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/0002-9343(90)90419-E_BIB11","first-page":"8333","article-title":"Phosphorylation of 3\u2032-azido-3\u2032-deoxythymidine and selective interaction of the 5\u2032-triphosphate with human immunodeficiency virus reverse transcriptase","volume":"83","author":"Furman","year":"1986"},{"key":"10.1016\/0002-9343(90)90419-E_BIB12","series-title":"A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter","first-page":"941","article-title":"Zidovudine in asymptomatic human immunodeficiency virus infection","volume":"322","author":"Volberding","year":"1990"},{"key":"10.1016\/0002-9343(90)90419-E_BIB13","series-title":"Houston: Programs and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Virologic and clinical response to combination zidovudine (AZT) and acyclovir (ACV) in AIDS-related complex (ARC)","author":"Collier","year":"1989"},{"key":"10.1016\/0002-9343(90)90419-E_BIB14","series-title":"A phase I and II study","first-page":"189","article-title":"Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections","volume":"110","author":"Merigan","year":"1989"},{"key":"10.1016\/0002-9343(90)90419-E_BIB15","series-title":"Proceedings of the Vth International Conference on AIDS","article-title":"2\u2032,3\u2032-Dideoxycytidine (ddC) in the treatment of patients with AIDS and ARC","author":"Gottlieb","year":"1989"},{"key":"10.1016\/0002-9343(90)90419-E_BIB16","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/AAC.31.10.1613","article-title":"Ribavirin antagonizes inhibitory effects of pyrimidine 2\u2032,3\u2032-dideoxynucleosides but enhances inhibitory effects of purine 2\u2032,3\u2032-dideoxynucleosides on replication of human immunodeficiency virus in vitro","volume":"31","author":"Baba","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0002-9343(90)90419-E_BIB17","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.2467383","article-title":"HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy","volume":"243","author":"Larder","year":"1989","journal-title":"Science"},{"key":"10.1016\/0002-9343(90)90419-E_BIB18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/AAC.34.3.436","article-title":"Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents using a quantitative plaque reduction assay","volume":"34","author":"Larder","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0002-9343(90)90419-E_BIB19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.2435003","article-title":"Ribavirin antagonizes the effect of azidothymidine on HIV replication","volume":"235","author":"Vogt","year":"1987","journal-title":"Science"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000293439090419E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000293439090419E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:38:46Z","timestamp":1756885126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/000293439090419E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["000293439090419E"],"URL":"https:\/\/doi.org\/10.1016\/0002-9343(90)90419-e","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[1990,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AIDS clinical trials group: Phase I\/II study of combination 2\u2032,3\u2032-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-9343(90)90419-E","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1990 Published by Excerpta Medica Inc.","name":"copyright","label":"Copyright"}]}}